IXC 6.67% 8.0¢ invex therapeutics ltd

DCF Valuation Model for Invex Therapeutics, page-125

  1. 343 Posts.
    lightbulb Created with Sketch. 23
    Anyone have a view on realistic timing of the next Capital Raise? My view is that the company will seriously start considering it once it is down to $20M cash in bank (based on other ASX businesses i have been associated with).
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.